Highlights d Report structures of ZIKV E protein and its complex with a broadly neutralizing antibody d ZIKV-E contains a unique, positively charged patch, which may influence host attachment d The ZIKV-E-antibody structure reveals antibody recognition of a conserved fusion loop d Antibody binds ZIKV-E and neutralizes circulating ZIKV strains in vitro and in mice SUMMARY Zika virus (ZIKV), a mosquito-borne flavivirus, is a current global public health concern. The flavivirus envelope (E) glycoprotein is responsible for virus entry and represents a major target of neutralizing antibodies for other flaviviruses. Here, we report the structures of ZIKV E protein at 2.0 Å and in complex with a flavivirus broadly neutralizing murine antibody 2A10G6 at 3.0 Å . ZIKV-E resembles all the known flavivirus E structures but contains a unique, positively charged patch adjacent to the fusion loop region of the juxtaposed monomer, which may influence host attachment. The ZIKV-E-2A10G6 complex structure reveals antibody recognition of a highly conserved fusion loop. 2A10G6 binds to ZIKV-E with high affinity in vitro and neutralizes currently circulating ZIKV strains in vitro and in mice. The E protein fusion loop epitope represents a potential candidate for therapeutic antibodies against ZIKV.
In Brief
Zika virus (ZIKV) is a mosquito-borne flavivirus. Dai et al. report the structures of ZIKV envelope (E) protein and its complex with a flavivirus broadly protective antibody, which reveals antibody recognition of a conserved fusion loop. Antibody binds to ZIKV-E with high affinity and neutralizes currently circulating ZIKV strains in mice.
Accession Numbers 5JHM 5JHL
INTRODUCTION Zika virus (ZIKV), a Flaviviridae family member, is a singlestranded, positive-sense RNA virus with a 10.7 Kb genome encoding a single polyprotein that is cleaved into three structural proteins (C, prM/M, and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) by viral and host proteases (Lindenbach and Rice, 2003) . ZIKV was first iso-lated from a sentinel rhesus monkey in the Zika Forest of Uganda in 1947 and can be transmitted to different species by mosquitoes of the genus Aedes (Dick et al., 1952) . For a long time, ZIKV has been commonly circulating in the tropical regions in African and Asian countries (Faye et al., 2014) and is classified into African and Asian genotypes by phylogenetic analysis (Haddow et al., 2012) . In 2007, a large epidemic of Asian genotype ZIKV was reported in Yap Island and Guam, Micronesia, and then between 2013 and 2014, a further outbreak was reported in French Polynesia (Cao-Lormeau and Musso, 2014) . The 2015 outbreak of ZIKV epidemic has caused more than 30,000 cases of infection in Brazil and rapidly spread to South and Central America, the Caribbean (Faria et al., 2016; Petersen et al., 2016) , and other countries including China . Recently, growing evidence has indicated that ZIKV infections are linked to fetal and newborn microcephaly and serious neurological complications, such as Guillain-Barre syndrome (GBS) (Mlakar et al., 2016; Petersen et al., 2016) . Moreover, it is noted that ZIKV can also possibly be transmitted by sexual behavior, with high viral loads detected in semen from infected patients (Mansuy et al., 2016) . To date, no clinically approved vaccines or therapeutics are available to control and prevent ZIKV infections; consequently, great efforts are being made to improve our understanding of ZIKV pathogenesis and vulnerability.
The recently published cryoelectron microscopy (cryo-EM) structures of ZIKV reveal that ZIKV displays a similar structure to other known flaviviruses (Kostyuchenko et al., 2016; Sirohi et al., 2016) . For flavivirus, mature virus particles contain 180 copies of the E protein and membrane (M) protein on the envelope and display an icosahedral arrangement in which 90 E dimers completely cover the viral surface (Kuhn et al., 2002; Zhang et al., 2013a) . Upon entry into host cells via endocytosis, the acidic endosomal environment triggers an irreversible conformational change in the E protein and a transition from a dimer to trimer formation that leads to the membrane fusion event (Modis et al., 2004) . In the ER, newly assembled virus progeny form immature virions and exhibit a spiky surface anchored with 60 trimeric protrusions of the E and precursor-membrane (prM) heterodimers (Plevka et al., 2011) . During virus maturation, a low pH environment in the trans-Golgi network (TGN) induces the reorganization of the E-prM heterodimers into E homodimers (Yu et al., 2008) . This structural rearrangement exposes the cleavage site of prM for digestion by the host protease, furin. After prM is cleaved, the protein dissociates from the particles upon release into the pH neutral extracellular space. During the maturation process, not all of E-prM heterodimer can be cleaved by the furin, and then uncleaved E-prM heterodimer will revert back to a spiky immature trimeric structure (Yu et al., 2008) .
Flavivirus E protein is responsible for virus entry and represents a major target for neutralizing antibodies. Thus far, a number of potent flavivirus type-specific neutralizing monoclonal antibodies (mAb) have been found to target E protein domain III (Beltramello et al., 2010; Oliphant et al., 2005) , while less potent cross-neutralizing mAbs have been shown to be specific for the fusion loop region or E-dimer region Rouvinski et al., 2015; Smith et al., 2013) . Although less potent, antibodies targeting the highly conserved fusion loop epitope (FLE) in domain II comprise a significant fraction of the humoral response against flaviviruses (Beltramello et al., 2010; Costin et al., 2013; Dejnirattisai et al., 2015; Lai et al., 2008; Oliphant et al., 2005 Oliphant et al., , 2007 Roberson et al., 2007; Smith et al., 2013; Tsai et al., 2013) . Moreover, FLE mAbs from several previous reports have shown protective efficacy against flavivirus in vivo (Beltramello et al., 2010; Deng et al., 2011; Lai et al., 2013; Sultana et al., 2009; Vogt et al., 2011) . Notably, most FLE mAbs are sensitive to the substitution of W101 in the fusion loop, with several of these also being sensitive to the substitution of G106, L107, and F108 Tsai et al., 2013) . Nevertheless, the molecular basis of the mAb-E interaction is still elusive. Here, we have determined the crystal structures of free ZIKV-E ectodomain protein in its dimeric form and its complex with the flavivirus broadly protective murine antibody 2A10G6. This antibody has previously been shown by our group to exhibit in vitro neutralization activity against dengue virus serotype 1-4 (DENV1-4), yellow fever virus (YFV) and West Nile virus (WNV) and to confer in vivo animal protection against DENV1-4 and WNV (Deng et al., 2011) . The crystal structure reveals that ZIKV-E resembles all the known flavivirus E structures, which have three distinct domains: a central b-barrel-shaped domain I, an elongated finger-like domain II, and a C-terminal immunoglobulin-like domain III. 2A10G6 binds to the ZIKV-E protein with a high binding affinity and neutralizes the ZIKV infection in vitro. Significantly, 2A10G6 completely protects mice against the circulating ZIKV strain in vivo, indicating a therapeutic potential. Furthermore, the complex structure of ZIKV-E/2A10G6 revealed that 2A10G6 binds to the tip of ZIKV-E domain II at a perpendicular angle, embedding the fusion loop of ZIKV-E in a hydrophobic hole formed by both the heavy chain and light chain. The hydrophobic residues W101, L107, and F108 form the majority of interactions between 2A10G6 and ZIKV-E and are highly conserved in the majority of flaviviruses, providing an explanation for the broadly neutralizing capacity of 2A10G6 (Deng et al., 2011) .
RESULTS

Structure of Prefusion-Form ZIKV-E Protein
Here, we expressed a large fragment (residues 1-409) of ZIKV-E protein ( Figure 1A ), lacking the stem region and C-terminal transmembrane anchor, in E. coli cells. Initially, we obtained insoluble inclusion bodies, and then we applied an in vitro refolding method to obtain soluble E protein (termed as sE). Square-like crystals were grown using the sitting drop vapor diffusion crystallization method, and the best crystal diffracted to a high resolution of 2.0 Å . The ZIKV sE structure was determined by molecular replacement method, using the dengue virus E protein structure (PDB: 1OKE) as a template. After several rounds of refinement, the final R free and R work values of 0.23 and 0.20, respectively, were obtained (Table S1 ).
The overall structure of ZIKV sE resembles previously reported flavivirus E protein structures (Lescar et al., 2001; Luca et al., 2012; Modis et al., 2003; Rey et al., 1995) and has three distinct domains: a central b-barrel (domain I), an elongated finger-like structure (domain II), and a C-terminal immunoglobulin-like module (domain III) ( Figure 1 ). The central domain I contains around 130 residues in three segments, residues 1-51, 132-192, and 280-295 ( Figure 1A ). The central domain I is folded into an eight-stranded b-barrel with an additional N-terminal A 0 strand ( Figure 1B ). The 150 loop (residues 147-161, between strands E 0 and F 0 ), which contains the potential N154 glycosylation site, likely represents a highly flexible loop in this domain due to a lack of electron density in this region. The finger-like domain II is formed by two segments, residues 52-131 (between strands D 0 and E 0 ) and residues 193-279 (between strands H 0 and I 0 ) ( Figure 1 ). The C-terminal domain III (residues 296-403) displays an IgG-like fold where the AA'BE sheet and disordered D strand are contacted by the cd loop of the adjacent sE monomer.
Domain II is responsible for the dimerization of sE monomer, leading to an extended, but interrupted, dimer interface, and thus there are ''holes'' in the dimer at either side of domain II (Figure 1B) . The central dimer interface is mainly constituted by the aB helix and j strand elements of each sE monomer, whereas the distal dimer interface is mainly created by the hydrophobic interaction between the cd loop and the crevice formed by domains I and III of the adjacent sE monomer ( Figure 1B) . The hydrophobic cd loop represents the fusion loop (residues 98-109), which is responsible for the membrane fusion between host cell and virus membranes during virus entry, and is highly conserved in flaviviruses.
In addition, comparison of an electrostatic surface potential map of ZIKV-E with other structure-known flavivirus E, including tick-borne encephalitis virus (TBEV), DENV2, DENV3, Japanese encephalitis virus (JEV), and WNV, revealed that a strong positive charge is found at the fusion loop region of E-dimer due to the presence of a conserved R99 residue at the protein surface. Notably, however, ZIKV displays a uniquely positively charged patch region adjacent to the fusion loop region in domain I due to the existence of R138, R164, and K166 unique to the ZIKV, making the two positively charged regions combine together (Figures S1 and S2).
Binding, Neutralization, and Protection of 2A10G6 to ZIKV Previously, we have reported a flavivirus broadly protective mouse monoclonal antibody 2A10G6 (Deng et al., 2011) . Phage-display biopanning experiments revealed that the 2A10G6 antibody bound to an epitope within the highly conserved flavivirus fusion loop peptide, the 98 DRXW 101 motif (Deng et al., 2011) . Further, in vitro neutralizing and in vivo animal protection experiments illustrated that 2A10G6 was able to potently neutralize the DENV1-4, WNV, and YFV and confer protection in a mouse model from lethal challenges of DENV1-4 and WNV (Deng et al., 2011) . As ZIKV E protein also displays a conserved 98 DRXW 101 motif, we hypothesized that 2A10G6 should also bind to ZIKV E protein.
The sE protein and 2A10G6 Fab eluted as single monomer peaks with high purity in gel filtration assays (Figure 2A ). Following incubation of the ZIKV sE and 2A10G6 Fab together at a molar ratio of 1:1.5, we found that the 2A10G6 Fab/sE complex eluted as a peak preceding the sE and 2A10G6 Fab monomer peaks, followed by a small 2A10G6 Fab peak (Figure 2A) . To further investigate the binding affinity between sE and 2A10G6 Fab, we performed surface plasmon resonance (SPR) experiments and found that 2A10G6 Fab binds to the ZIKV sE protein with a high affinity of 2.7 nM ( Figure 2B) .
To investigate the neutralizing potential of 2A10G6 to ZIKV infection, the current circulating ZIKV Asian linage strain SZ01 isolated from the serum of an imported case in China was used (Deng et al., 2016) . The in vitro neutralizing activity of mAb 2A10G6 for ZIKV was assessed using a plaque reduction assay; indeed, the antibody exhibited neutralizing activity, with a 50% plaque reduction neutralization titer (PRNT 50 ) of 249 mg/ml ( Figure 3A ). Though not as high as those for dengue virus serotype 1-4 (DENV1-4) and yellow fever virus (YFV), a single dose of 500 mg 2A10G6 mAb provided complete protection in vivo against ZIKV infection in the A129 mouse model in a 60% mortality setting of the control group ( Figure 3B ).
Complex Structure of E Protein with 2A10G6 Antibody
In order to elucidate the molecular basis of this interaction, the ZIKV sE and 2A10G6 Fab were incubated at a molar ratio of 1:1, and a crystallization screen was performed with the mixed protein complex. An X-ray diffraction dataset was collected, and the complex structure was determined by molecular replacement at a resolution of 3.0 Å .
The solved complex structure reveals that 2A10G6 binds to the tip of the finger-like domain II at a perpendicular angle via the fusion loop and bc loop. In particular, the fusion loop enters into a hole formed by both heavy and light chains, while the bc loop contacts only the heavy chain ( Figure 4A ). Seven residues (W101, G102, G104, C105, G106, L107, and F108) in the fusion loop and two residues (T76 and Q77) in the bc loop of ZIKV sE contribute to the binding of 2A10G6 ( Figure 4B and Table 1) . Notably, the projecting residue W101 deeply inserts the hole in the binding interface of 2A10G6 ( Figure 4B ). For 2A10G6, 13 residues (T38, H40, G55, I56, D57, N60, G62, T63, N64, R104, Y107, A108, and L109) from the heavy chain and six residues (Q91, Y93, N94, S95, Y96, and P97) from the light chain participate in the interaction with ZIKV sE ( Figure 4C ). The heavy-chain residues (H40, R104, A108, and L109) and the light-chain residues (Q91, Y93, and P97) constitute the inner hydrophobic ring of the hole that can tightly envelope the aromatic residue W101 in the fusion loop of sE, while the other residues form the outer ring of the hole.
Detailed structural analysis demonstrates that four secondary elements of 2A10G6 surround the tip of the finger-like domain of sE, including three elements (HFR2 strand, HCDR2 and HCDR3 loops) from the heavy chain and one element (LCDR3 loop) from the light chain ( Figure 5A ). T38 and H40 in the HFR2 strand contribute 23 contacts, including one hydrogen bond between H40 and the main chain of G106 in the fusion loop of sE ( Figure 5B and Table 1 ). G55, I56, D57, N60, G62, T63, and N64 in the HCDR2 loop contribute 45 contacts, including two hydrogen bonds between N60 and the residues (T76 and Q77) in the bc loop of sE and one hydrogen bond between N64 and the main chain of F108 ( Figure 5B and Table 1 ). R104, Y107, A108, and L109 in the HCDR3 loop contribute 62 contacts, including one hydrogen bond between R104 and the main chain of W101 in the fusion loop of sE ( Figure 5B and Table 1 ). Q91, Y93, N94, S95, Y96, and P97 in the LCDR3 loop contribute 63 contacts, which are mainly comprised of non-polar interactions with the aromatic residues W101 and F108 in fusion loop of sE ( Figure 5B and Table 1 ). Reciprocally, the hydrophobic residues W101, L107, and F108 in the fusion loop of sE contribute the majority (145 of 197 contacts) of the interaction with 2A10G6.
Comparison of Fusion Loop Targeting Neutralizing
Antibodies to Flavivirus E During the maturation of flaviviruses, E protein domain II forms the binding partner of precursor membrane glycoprotein (prM) ( Figure 6A ). As immature flavivirus particles are transported through the cellular secretory pathway, cellular furin proteases cleave prM resulting in the release of the pr peptide and formation of mature virus particles, concurrent with the change from an acidic to neutral pH environment. Interestingly, 2A10G6 binds to the tip of domain II at a perpendicular angle ( Figure 6B ), which should not interfere with the prM binding site on the side of domain II ( Figure 6A ). This indicates that 2A10G6 is able to bind to immature virus particles or partially immature virus particles but is unable to bind to fully mature virus particles, which present in a compact E-dimer arrangement on the envelope where the fusion loop is buried in a crevice formed by domain I and III from the other monomer.
Similar FLE antibodies have been found in a significant fraction of the humoral response to flaviviruses in humans, and W101, G106, L107, and F108 have been reported as the key residues for the binding of these FLE antibodies (Beltramello et al., 2010; Costin et al., 2013; Dejnirattisai et al., 2015; Lai et al., 2008; Oliphant et al., 2005 Oliphant et al., , 2007 Roberson et al., 2007; Smith et al., 2013; Tsai et al., 2013) . Previously, only the complex structure of WNV sE protein and the FLE antibody E53 had been solved, illustrating that E53 binds to the tip of domain II at a tilted angle on the opposite side of prM binding site ( Figures 6C and  S3 ) (Cherrier et al., 2009) , away from the canonical FLE antibody binding-dependent aromatic residues W101 and F108 in the fusion loop. Our 2A10G6/ZIKV sE complex structure reveals the binding mode of classical, W101, and F108 amino acid substitution-sensitive FLE antibodies. In contrast to FLE antibodies, a previous study on broadly neutralizing human antibodies against dengue viruses revealed recognition determinants to be at a serotype-invariant site at the E-dimer interface, including the exposed main chain of the fusion loop and two conserved glycan chains, which also create the binding site for the prM (Figures 6D and S3 ) (Rouvinski et al., 2015) . These E-dimer-dependent (EDE) neutralizing antibodies are able to bind to mature or partially immature virus particles but are unable to bind to the immature virions.
DISCUSSION
The association of ZIKV infection with microcephaly in fetuses and neurological diseases such as GBS has caused international concern (Petersen et al., 2016). Here, we found that our previously reported potently neutralizing antibody 2A10G6, which targets the fusion loop region of some flavivirus E proteins, can also protect against ZIKV infection in vivo and can potentially be used as a therapeutic candidate for ZIKV infection. A complex crystal structure of 2A10G6 and ZIKV-E revealed that 2A10G6 forms the majority of contacts with the hydrophobic residues of the fusion loop, including W101, L107, and F108. These three residues are highly conserved in all of the isolated ZIKV strains and in most of the human-infected flaviviruses, including DENV 1-4, WNV, and YFV ( Figure S2) (Deng et al., 2011) . Structural models also show that 2A10G6 likely recognizes the DENV-E and WNV-E via a similar binding mode ( Figure S4) .
Previously, two classes of dengue virus broadly neutralizing antibodies have been revealed: the FLE-specific neutralizing antibodies and the EDE-specific neutralizing antibodies (Dejnir- , 2015) . The FLE-specific antibodies usually have a lower neutralizing capacity and higher antibody-dependent enhancement (ADE) effect than the EDE-specific antibodies . However, the FLE-specific antibodies are generally cross-reactive and are able to neutralize different flaviviruses. Structural studies of EDE-specific neutralizing antibodies have revealed that the recognition determinants are found at a serotype-invariant site at the E-dimer interface, including the exposed main chain of the fusion loop and the two conserved glycan chains (N67-and N153-linked glycans) (Rouvinski et al., 2015) . These two glycosylation sites are not highly conserved in other flaviviruses. Moreover, ZIKV does not possess the N67-linked glycosylation site, and the N154-linked glycosylation site (equivalent to the N153-linked glycosylation site in DENV) is absent in some of the isolated ZIKV strains (Table S2 ). Furthermore, several residues in b strand, 150 loop, ij loop, and A strand, which are critical for DENV EDE mAb binding, are not conserved in ZIKV and other flaviviruses ( Figure S2 ). Importantly, as ZIKV sE structure displays a unique positively charged patch at the binding regions of EDE antibodies (Figure S1 ), the EDE-specific antibodies may not be effective against ZIKV infection. However, many other known flavivirus FLE-specific antibodies, which target the highly conserved fusion loop, may be able to neutralize ZIKV, as confirmed by our neutralizing profile of 2A10G6. Interestingly, during the preparation of our manuscript, the cryo-EM structure of ZIKV was published, illustrating an intact 150 loop and N154 glycosylation site that may function as a host attachment site for the virus. Herein, we describe a unique, positively charged patch that surrounds the 150 loop of ZIKV, which may also affect virus attachment and hence influence transmission and disease.
We propose two possible explanations for the protection mechanisms of 2A10G6. First, during flavivirus infection, the hidden epitopes for neutralizing antibodies such as the FLE-specific mAbs may become exposed either through the incomplete cleavage of prM that has been shown to create a ''mosaic'' of both mature and immature viruses or through virus conformational transition at physiological temperatures (above 34 C), as has been described in DENV (Fibriansah et al., 2013; Plevka et al., 2011; Zhang et al., 2013b) . Blocking the key residues (such as W101) for virus fusion may neutralize the virus infection in vivo. Furthermore, recent work on HIV has also demonstrated that the fusion peptide may represent a viable target for broadly neutralizing mAbs in another viral system (Chen et al., 2014; Frey et al., 2008; Lai et al., 2014) . This hypothesis supports the previously proposed concept that both immature and mature flavivirus virions contribute to infection and pathogenesis (Nelson et al., 2008) . Second, the protection efficacy of 2A10G6 in ZIKV may not be due merely to its weakly neutralizing activity, but rather may be through another effector functional mechanism. As recently demonstrated, Fcg receptor and complement-dependent effector can also provide in vivo protection against other flaviviruses (Vogt et al., 2011) . The similar mechanism has also been extensively elucidated in antibody therapy against other viruses including Ebola and influenze (Audet et al., 2014; Qiu et al., 2012; Wilson et al., 2000; Zeitlin et al., 2011 ) (DiLillo et al., 2016 .
In summary, we have shown 2A10G6 to be able to neutralize and provide protection against ZIKV via recognition of the ZIKV E protein fusion loop region. As we have previously shown 2A10G6 to be able to efficiently neutralize many other flaviviruses (Deng et al., 2016) , including DENV1-4, YFV, and WNV, which exhibit this highly conserved fusion loop, it is likely that the binding modes of 2A10G6 are the same as that of ZIKV in these flaviviruses. This antibody, especially after being humanized, may represent an auspicious therapeutic for the treatment of flavivivirus infection.
EXPERIMENTAL PROCEDURES
Protein Preparation, Expression, and Purification
The coding sequence for ectodomain residues 1-409 of envelope protein (sE) from ZIKV BeH818995 strain (GeneBank: KU365777) were codon optimized and cloned into pET21a vector with a C-terminal His 6 -tag. The sE proteins were expressed in Escherichia coli strain BL21(DE3) as inclusion bodies and then refolded in vitro using the method as previously described , with some modifications. Briefly, aliquots of inclusion body were diluted dropwise into a stirring refolding buffer (100 mM Tris [pH 8.0], 400 mM L-Arg HCl, 2 mM EDTA, 5 mM reduced glutathione, 0.5 mM oxidized glutathione, and 5% glycerol) for overnight refolding. Subsequently, the refolded protein was concentrated using an Amicon 400 concentrator with 30 kDa cutoff membrane and then adjusted to 20 mM Tris (pH 8.0), 50 mM NaCl, and 5% glycerol. sE proteins were further purified in an Ä KTA Pure System by gel filtration on a HiLoad 16/60 Superdex 200 PG column (GE Healthcare).
The coding sequences for heavy chain and light chain of murine mAb 2A10G6 were codon optimized and cloned into pFastBac-Dual for expression as a Fab. A previously described gp67 signal peptide sequence was added to the N terminus of both chains for protein secretion, and His 6 -tag was fused at the C terminus of heavy chain for affinity purification. 2A10G6 Fab was expressed by Bac-to-Bac baculovirus expression system in Tricoplusia ni (High 5) cells (Invitrogen) as previously described (Shi et al., 2013; Zhang et al., 2010) . Soluble Fab was harvested from the culture supernatants by metal affinity chromatography using a HisTrap HP 5 ml column (GE Healthcare) and subsequently purified by gel filtration on a Hiload 16/60 Superdex 200 PG column (GE Healthcare) in buffer consisting of 20 mM Tris (pH 8.0) and 150 mM NaCl.
For functional analysis, mAb 2A10G6 was used, and its preparation has been described previously (Deng et al., 2011) . Briefly, the hybridoma producing mAb 2A10G6 (IgG1) was maintained by limiting dilution and subsequently purified from mouse ascites using Protein G affinity columns (GE Healthcare).
Analytical Gel Filtration and Purification of Fab/E Complex
The 2A10G6 Fab was mixed with purified ZIKV sE protein for 30 min incubation at 4 C. The samples from individual Fab, E protein, and their mixtures were then loaded onto calibrated Superdex 200 GL column (GE Healthcare), respectively. The chromatographs were recorded and overlaid. The pooled proteins were analyzed on 12% SDS-PAGE gel and stained with Coomassie blue.
The 2A10G6 Fab/ZIKV-E complex was separated from excess Fab by size-exclusion chromatography, and the buffer was exchanged to 20 mM Tris (pH 8.0), 50 mM NaCl, and 5% glycerol. The Fab/ZIKV-E complex was further concentrated by 30 kDa cutoff membrane (Amicon) for subsequent crystallization.
Neutralization Assay
Neutralizing activity of mAb 2A10G6 was measured using a standard plaque reduction neutralization with BHK21 cells as previously described (Deng et al., 2011) . Briefly, 5-fold serial dilutions of mAb 2A10G6 were added to approximately 200 PFU of ZIKV SZ01 strain (Deng et al., 2016) and incubated for 1 hr at 37 C. Then, the mixture was added to BHK21 cell monolayers in a 12-well plate in duplicate and incubated for 1 hr at 37 C. The mixture was removed, and 1 ml of 1.0% (w/v) LMP agarose (Promega) in DMEM plus 4% (v/v) FBS was layered onto the infected cells. After further incubation at 37 C for 4 days, the wells were stained with 1% (w/v) crystal violet dissolved in 4% (v/v) formaldehyde to visualize the plaques. PRNT 50 values were determined using non-linear regression analysis.
Animal Protection Experiment ZIKV SZ01 strain was isolated as previously described (Deng et al., 2016) and was propagated in C6/36 cells. For antibody protection against ZIKV challenge, groups of 5-week-old A129 male mice (n = 5) were injected intraperitoneally (i.p.) with 10 5 PFU of ZIKV. 24 hr post infection, mice were passively transferred a single inoculation of 500 mg antibody 2A10G6, or PBS as control via i.p. injection. The animals were monitored daily for death. All experiments were carried out according to ethical guidelines and approved by the Y96 3 F108 P97 1, 9 W101, F108 a Numbers represent the number of atom-to-atom contacts between the antibody residues and the sE residues, which were analyzed by the Contact program in CCP4 suite (the distance cutoff is 4.5 Å ). b Numbers in the parentheses represent the number of hydrogen bonds between the antibody residues and the sE residues, which were analyzed by the Contact program in CCP4 suite (the distance cutoff is 3.5 Å ).
Experimental Animal Ethic and Welfare Committee of Beijing Institute of Microbiology and Epidemiology.
Crystallization, Data Collection, and Structure Determination Crystallization trials were performed in sitting drops of 600 ml. All crystals were obtained by mixing equal volumes of protein and reservoir solution, using a Mosquito LCP robot (TTP LabTech). Diffraction-quality crystals of free sE were obtained at 4 C in a condition consisting of 0.2 magnesium acetate tetrahydrate, 0.1 sodium cacodylate (pH 6.5), and 20% w/v PEG8000 at a protein concentration of 10 mg/ml. Diffraction-quality crystals of 2A10G6 Fab/sE Figure 5 . Analysis of the Detailed Interaction between the 2A10G6 and ZIKV-E (A) Four polypeptide elements, three from the heavy chain (light pink) and one from the light chain (cyan), surround the domain II tip of ZIKV-E. (B) The heavy chain forms five hydrogen bonds (green dashed lines) with the ZIKV-E residues. The hydrophobic residues W101, L107, and F108 in the fusion loop contribute most of the contacts between 2A10G6 and ZIKV-E. Figure 6 . Comparison with Other Fusion Loop-Targeting Neutralizing Antibodies (A) Structure of prM-E heterodimer of dengue virus serotype 2 (DENV2) (PDB: 3C5X). The pr peptide is shown in green, with domain coloring described previously in Figure 1. (B) Structure of ZIKV-E/2A10G6 complex with coloring described previously in Figure 5 . (C) Structure of fusion loop epitope (FLE)-specific E53 in complex with the West Nile virus E protein (PDB: 3I50). The heavy chain is in lemon, and the light chain is in wheat. (D) Structure of E-dimer epitope (EDE)-specific antibody A11 in complex with the DENV2 E protein (PDB: 4UT7). The heavy chain is in light gray, and the light chain is in light orange. See also Figures  S2 and S3 and Table S2 . complex were finally obtained at 18 C in a condition consisting of 0.2 M sodium chloride, 0.1 Na/K phosphate (pH 6.5), and 25% PEG1000.
Diffraction data were collected at Shanghai Synchrotron Radiation Facility (SSRF) BL17U (wavelength, 0.97930 Å ). For data collection, all crystals were cryo-protected by briefly soaking in reservoir solution supplemented with 20% (v/v) glycerol before flash-cooling in liquid nitrogen. All the datasets were processed with HKL2000 software (Otwinowski and Minor, 1997) . The structures of sE and 2A10G6 were both determined by the molecular replacement method using Phaser (Read, 2001) with previously reported dengue virus 2 E protein structure (PDB: 1OKE) as the search model. The E-2A10G6 complex structure was further determined by the molecular replacement with the solved monomer structure of sE and the Fab structure (PDB: 4GMS) as the search models, respectively. The atomic models were completed with Coot (Emsley and Cowtan, 2004) and refined with phenix.refine in Phenix (Aad et al., 2010) , and the stereochemical qualities of the final models were assessed with PROCHECK (Laskowski et al., 1993) . Data collection, processing, and refinement statistics are summarized in Table S1 .
Surface Plasmon Resonance Assay
The SPR analysis was carried out using a BIAcore 3000 machine with CM5 chips (GE Healthcare) at room temperature (25 C). The buffers for all proteins used were exchanged to a BIAcore buffer consisting of 10 mM HEPES (pH 7.5), 150 mM NaCl, and 0.005% (v/v) Tween-20 via gel filtration. The ZIKV sE protein was immobilized on the chip at about 1,000 response units (RU). Subsequently, gradient concentrations of 2A10G6 Fab (0, 1.9, 3.9, 7.8, Cell Host & Microbe 19, 1-9, May 11, 2016 7
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